A treatment with flavokawain A, a phytochemical with potential anti-tumor activity, induced a G1 phase cell-cycle arrest in wt-p53 bladder cancer cells in contrast to induced G2 phase cell-cycle arrest in mt-p53 bladder cancer cells [56]. Here, TP53 is linked to urinary bladder carcinoma.